Oregon 2019 Regular Session Status: In Committee

HB 3192 — Relating to assessment imposed on manufacture of prescription opioids; prescribing an effective date; providing for revenue raising that requires approval by a three-fifths majority.

Last action — In committee upon adjournment.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2019 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Imposes annual assessment on manufacture of prescription opioids. Applies to opioids dispensed on or after January 1, 2020. Takes effect on 91st day following adjournment sine die.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 3192 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Referred to Revenue by prior reference.

  3. Without recommendation as to passage and be referred to Revenue by prior reference.

  4. Work Session held.

  5. Referred to Health Care with subsequent referral to Revenue.

  6. First reading. Referred to Speaker's desk.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 89 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (89)

89 members have not signed on to this bill.

Show all 89 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Heard and Reported Out

Passed 10 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 7001
Republican 2000
Democrat 1000
Total 10001
% of votes cast 91%0%0%9%
How each member voted (11)
Member Party Vote
Alissa Keny-Guyer — Yea
Andrea Salinas — Yea
Denyc Boles — Yea
Mitch Greenlick — Not Voting
Rachel Prusak — Yea
Ron Noble — Yea
Teresa Alonso Leon — Yea
Tiffiny Mitchell — Yea
Rob Nosse Democrat Yea
Cedric Hayden Republican Yea
Christine Drazan Republican Yea

Official roll call →

Subjects

taxation healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 3192 do?
Imposes annual assessment on manufacture of prescription opioids. Applies to opioids dispensed on or after January 1, 2020. Takes effect on 91st day following adjournment sine die.
Who sponsors HB 3192?
HB 3192 is sponsored by Barbara Smith Warner.
What is the current status of HB 3192?
This bill died with 2019 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 3192?
Track HB 3192 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 3192

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 3192

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →